Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katG: a decade of experience.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Characteristics of pathogenic Neisseria meningitidis in Moscow: prevalence of ‘non- European’ strains Irina S. Koroleva, Alexander E. Platonov, Arie van.

Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm S.O. Simons, T. van der Laan,

R. Dumke, H. von Baum, P.C. Lück, E. Jacobs

Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods A. Ducournau, L. Bénéjat, E. Sifré, E. Bessède,

L. Boyanova Clinical Microbiology and Infection

Molecular epidemiology and prevalence of mutations conferring rifampicin and isoniazid resistance in Mycobacterium tuberculosis strains from the southern.

E. Svensson, J. Millet, A. Lindqvist, M. Olsson, M. Ridell, N. Rastogi

Gut bacterial microbiota and obesity

Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Herpes zoster in non-hospitalized children

Mycobacterial peritonitis: difference between non-tuberculous mycobacteria and Mycobacterium tuberculosis C.-C. Shu, J.-T. Wang, J.-Y. Wang, C.-J. Yu,

Host factors are more important in predicting recurrent Clostridium difficile infection than ribotype and use of antibiotics Y.H. van Beurden, S. Nezami,

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

A.K. Reddy, P. Garg, I. Kaur Clinical Microbiology and Infection

In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the.

J.-P. Van geertruyden Clinical Microbiology and Infection

Mycobacterium genavense in the Netherlands: an opportunistic pathogen in HIV and non-HIV immunocompromised patients. An observational study in 14 cases

Rapid and accurate detection of rifampin and isoniazid-resistant Mycobacterium tuberculosis using an oligonucleotide array W.-L. Huang, Z.-J. Hsu, T.C.

Quinolone resistance among Shigella spp

R. Cantón Clinical Microbiology and Infection

Genital Chlamydia trachomatis infections

Multicentre surveillance of prevalence of the 23S rRNA A2058G and A2059G point mutations and molecular subtypes of Treponema pallidum in Taiwan, 2009–2013

Public health significance of invasive mosquitoes in Europe

E. Cambau, M. Drancourt Clinical Microbiology and Infection

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Potential risk factors for infection with Candida spp

Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan P.R. Hsueh, S.P. Tseng, L.J. Teng, S.W. Ho

Clinical Microbiology and Infection

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum.

Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente

Impact of antibiotic restrictions: the pharmaceutical perspective

Vector control: a cornerstone in the malaria elimination campaign

S. M. Arend, E. Cerdé de Palou, P. de Haas, R. Janssen, M. A. Hoeve, E

Sofie Arens, Jan Verhaegen, Ludo Verbist

Characterization of Mycobacterium tuberculosis isolated from cancer patients with suspected tuberculosis infection in Egypt: identification, prevalence,

Training for the infectious diseases speciality in Norway

E.C. Böttger Clinical Microbiology and Infection

Laboratory diagnosis and biosafety issues of biological warfare agents

Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections P.S. Hicks, B.

S. Borrell, S. Gagneux Clinical Microbiology and Infection

M.W. Borgdorff, D. van Soolingen Clinical Microbiology and Infection

Elements of design: the knowledge on which we build

G. Pappas Clinical Microbiology and Infection

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

Laboratory diagnosis of Clostridium difficile disease

N. Maggi-Solcà, C. Valsangiacomo, J.-C. Piffaretti

J. Garau Clinical Microbiology and Infection

T.M. File Clinical Microbiology and Infection

Tuberculosis drug-resistance in Lisbon, Portugal: a 6-year overview

Update on antifungal resistance in Aspergillus and Candida

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Clinical infection services—the Leiden experience

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Genomic diversity of group A rotavirus strains in patients aged 1–36 months admitted for acute watery diarrhoea in northern India: a hospital-based study

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Acquisition of second-line drug resistance and extensive drug resistance during recent transmission of Mycobacterium tuberculosis in rural China Y. Hu,

Impact of antibiotic restrictions: the patient's perspective

L. Bichaud, R. P. Piarroux, A. Izri, L. Ninove, C. Mary, X

Localized Mycobacterium avium complex infection in a patient on HAART

The future of diagnostic bacteriology

Presentation transcript:

Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katG: a decade of experience in The Netherlands H.R. van Doorn, P.E.W. de Haas, K. Kremer, C.M.J.E. Vandenbroucke-Grauls, M.W. Borgdorff, D. van Soolingen Clinical Microbiology and Infection Volume 12, Issue 8, Pages 769-775 (August 2006) DOI: 10.1111/j.1469-0691.2006.01495.x Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Association between the MIC of isoniazid and a mutation at amino-acid 315 of katG in Mycobacterium tuberculosis isolates. Clinical Microbiology and Infection 2006 12, 769-775DOI: (10.1111/j.1469-0691.2006.01495.x) Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Age group distribution for Dutch and non-Dutch tuberculosis patients. Clinical Microbiology and Infection 2006 12, 769-775DOI: (10.1111/j.1469-0691.2006.01495.x) Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions